Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response
Abstract Clusterin (CLU) is a molecular chaperone that participates in a variety of biological processes. Recent studies indicate its possible involvement in the development of bone erosions and autoimmunity. The aim of this study was to investigate its serum concentrations in patients with early rh...
Guardado en:
Autores principales: | Tereza Kropáčková, Heřman Mann, Olga Růžičková, Olga Šléglová, Lucia Vernerová, Veronika Horváthová, Michal Tomčík, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/227e667eadb7435baccf2f0805b6c601 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
por: Klára Prajzlerová, et al.
Publicado: (2021) -
Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort.
por: Ondřej Sglunda, et al.
Publicado: (2014) -
S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils
por: Adéla Navrátilová, et al.
Publicado: (2021) -
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
por: Hana Štorkánová, et al.
Publicado: (2021) -
Clusterin and Psoriasis; What is the Relation?
por: Osama Hashem, et al.
Publicado: (2020)